Sunshine Biopharma, Inc. (SBFM)
1.13
-0.04
(-3.42%)
USD |
NASDAQ |
Sep 03, 13:27
Sunshine Biopharma Price : 1.13 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 1.14 | 1.19 | 1.12 | 1.17 | 129984.0 |
| Sep 01, 2026 | 1.12 | 1.15 | 1.11 | 1.13 | 107190.0 |
| Aug 31, 2026 | 1.14 | 1.23 | 1.105 | 1.12 | 368303.0 |
| Aug 28, 2026 | 1.28 | 1.28 | 1.14 | 1.15 | 451762.0 |
| Aug 27, 2026 | 1.25 | 1.30 | 1.18 | 1.27 | 1.021M |
| Aug 26, 2026 | 1.30 | 1.31 | 1.01 | 1.24 | 9.362M |
| Aug 25, 2026 | 1.15 | 1.166 | 1.121 | 1.14 | 52505.00 |
| Aug 24, 2026 | 1.17 | 1.17 | 1.12 | 1.16 | 84347.00 |
| Aug 21, 2026 | 1.15 | 1.17 | 1.14 | 1.16 | 102643.0 |
| Aug 20, 2026 | 1.16 | 1.16 | 1.105 | 1.16 | 137216.0 |
| Aug 19, 2026 | 1.19 | 1.23 | 1.09 | 1.17 | 504601.0 |
| Aug 18, 2026 | 1.10 | 1.18 | 1.084 | 1.12 | 126168.0 |
| Aug 17, 2026 | 1.17 | 1.200 | 1.03 | 1.12 | 344465.0 |
| Aug 14, 2026 | 1.18 | 1.21 | 1.14 | 1.15 | 104381.0 |
| Aug 13, 2026 | 1.21 | 1.21 | 1.16 | 1.20 | 182351.0 |
| Aug 12, 2026 | 1.22 | 1.250 | 1.20 | 1.21 | 117626.0 |
| Aug 11, 2026 | 1.21 | 1.25 | 1.17 | 1.23 | 202403.0 |
| Aug 10, 2026 | 1.20 | 1.238 | 1.19 | 1.22 | 345558.0 |
| Aug 07, 2026 | 1.50 | 1.50 | 1.12 | 1.23 | 11.23M |
| Aug 06, 2026 | 1.36 | 1.465 | 1.32 | 1.40 | 253694.0 |
| Aug 05, 2026 | 1.33 | 1.39 | 1.21 | 1.33 | 254268.0 |
| Aug 04, 2026 | 1.22 | 1.52 | 1.16 | 1.31 | 2.409M |
| Aug 03, 2026 | 1.17 | 1.209 | 1.12 | 1.17 | 78464.00 |
| Jul 31, 2026 | 1.24 | 1.24 | 1.15 | 1.17 | 87677.00 |
| Jul 30, 2026 | 1.33 | 1.34 | 1.10 | 1.23 | 1.235M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.45 |
| Alnylam Pharmaceuticals, Inc. | 265.44 |
| Anika Therapeutics, Inc. | 21.11 |
| Savara, Inc. | 5.33 |
| Vericel Corp. | 40.61 |
Price Related Metrics
| PS Ratio | 0.0222 |
| Price to Book Value | 0.0980 |
| Earnings Yield | -905.0% |
| Market Cap | 2.699M |